Sivaprasad S, Prevost AT, Bainbridge J. et al. Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial. BMJ Open 2015; 5: e8405 doi:10.1136/bmjopen-2015-008405
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.